September 2002 Supplement Research Papers

• Undated – 1 supplement study

  • Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.

    • 2002-09
    • Clinical Trial
    • FEMS Immunology & Medical Microbiology 34(1)
    • • Q. Shu
      • H. Gill

    • PubMed: 12208607
    • DOI: 10.1111/J.1574-695X.2002.TB00603.X

    7 Insights on

    • Reduced Bacterial Translocation
    • Reduced Cumulative Morbidity Rates
    • Improved Phagocytic Activity
    • Reduced Infection Severity
    • Enhanced Phagocytic Activity
    • Increased Intestinal Anti-E. coli IgA Antibody Responses
    • Increased Intestinal Anti-E. coli IgA Levels

    • Low evidence
    • Highly Cited
    • Animal Study